Medibio Limited advises that Mr. Peter Carlisle has tendered his resignation from his position as Non-Executive Director and Lead Independent Director of the Company, effective on 10 June 2022, in order to focus his time and efforts on the activities of the Growth and Advocacy Advisory Board. Peter has made a considerable contribution to the Company over many years, and that he will continue to contribute as Chairman of the Company's Growth and Advocacy Board. Given the Company is moving into a critical time in the Company's development, Peter's expertise in directing the Growth and Advocacy Advisory Board will be significant.